It’s been almost a year since the World Health Organization declared the coronavirus outbreak a pandemic.
And the virus is persisting: A downward trend in the U.S. caseload has stalled, and concern about the impact of variants is growing. Yet inoculations are on the rise, and the F.D.A. has approved Johnson & Johnson’s single-dose vaccine, the third to be approved in the U.S.
Today, we check in on the latest about the coronavirus.
Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.
For more information on today’s episode, visit nytimes.com/thedaily.
Transcripts of each episode will be made available by the next workday.
Connect with listeners
Podcasters use the RadioPublic listener relationship platform to build lasting connections with fansYes, let's begin connecting
Find new listeners
Understand your audience
Engage your fanbase